Australia markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.69+0.44 (+5.33%)
At close: 04:00PM EST
8.46 -0.23 (-2.65%)
After hours: 06:16PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts3234
Avg. Estimate0.03-0.720.08-0.98
Low estimate-0.77-0.87-0.72-3.7
High estimate1.17-0.571.213.56
Year ago EPS-1.740.34-0.510.08
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts3143
Avg. Estimate75.73M66M251.48M290.82M
Low estimateN/A66M159M10M
High estimate192.18M66M351.37M637.46M
Year ago sales48.63M65.98M48.63M251.48M
Sales growth (year/est)55.70%0.00%417.10%15.60%
Earnings history29/09/202030/03/202129/06/202129/09/2021
Est. EPS-1.05-0.050-0.05
Actual EPS-1.740.340.02-0.34
Difference-0.690.390.02-0.29
Surprise %-65.70%780.00%N/A-580.00%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate0.03-0.720.08-0.98
7 days ago0.03-0.720.08-0.98
30 days ago-0.39-0.74-0.180.3
60 days ago0.36-0.290.5815.6
90 days ago0.47-0.290.6213.06
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days212N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAVIRIndustrySector(s)S&P 500
Current qtr.101.70%N/AN/AN/A
Next qtr.-311.80%N/AN/AN/A
Current year115.70%N/AN/AN/A
Next year-1,325.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A